CLINICAL_TRIALS
trial_result
· 2021-04-22
Clinical Trial Update: A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis [Phase 2]
Summary
Phase 2 trial of VX-659 combination therapy in cystic fibrosis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-22